PMC:7358770 / 28097-28298 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"980","span":{"begin":79,"end":84},"obj":"Gene"},{"id":"981","span":{"begin":89,"end":92},"obj":"Gene"},{"id":"982","span":{"begin":93,"end":96},"obj":"Gene"},{"id":"983","span":{"begin":97,"end":100},"obj":"Gene"},{"id":"984","span":{"begin":9,"end":12},"obj":"Species"},{"id":"985","span":{"begin":173,"end":176},"obj":"Species"}],"attributes":[{"id":"A980","pred":"tao:has_database_id","subj":"980","obj":"Gene:4790"},{"id":"A981","pred":"tao:has_database_id","subj":"981","obj":"Gene:22882"},{"id":"A982","pred":"tao:has_database_id","subj":"982","obj":"Gene:5609"},{"id":"A983","pred":"tao:has_database_id","subj":"983","obj":"Gene:2048"},{"id":"A984","pred":"tao:has_database_id","subj":"984","obj":"Tax:10407"},{"id":"A985","pred":"tao:has_database_id","subj":"985","obj":"Tax:10407"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The anti-HBV mechanism of PGS may be associated with appropriate activation of NF-κB and Raf/MEK/ERK signaling pathways to enhance the interferon system, and interfere with HBV transcription (Fig. 7 )."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T112","span":{"begin":26,"end":29},"obj":"Disease"}],"attributes":[{"id":"A112","pred":"mondo_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/MONDO_0010574"}],"text":"The anti-HBV mechanism of PGS may be associated with appropriate activation of NF-κB and Raf/MEK/ERK signaling pathways to enhance the interferon system, and interfere with HBV transcription (Fig. 7 )."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T310","span":{"begin":65,"end":75},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T311","span":{"begin":83,"end":84},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T312","span":{"begin":101,"end":110},"obj":"http://purl.obolibrary.org/obo/SO_0000418"}],"text":"The anti-HBV mechanism of PGS may be associated with appropriate activation of NF-κB and Raf/MEK/ERK signaling pathways to enhance the interferon system, and interfere with HBV transcription (Fig. 7 )."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T416","span":{"begin":79,"end":81},"obj":"Chemical"},{"id":"T419","span":{"begin":93,"end":96},"obj":"Chemical"},{"id":"T420","span":{"begin":135,"end":145},"obj":"Chemical"}],"attributes":[{"id":"A416","pred":"chebi_id","subj":"T416","obj":"http://purl.obolibrary.org/obo/CHEBI_141424"},{"id":"A417","pred":"chebi_id","subj":"T416","obj":"http://purl.obolibrary.org/obo/CHEBI_25573"},{"id":"A418","pred":"chebi_id","subj":"T416","obj":"http://purl.obolibrary.org/obo/CHEBI_1224"},{"id":"A419","pred":"chebi_id","subj":"T419","obj":"http://purl.obolibrary.org/obo/CHEBI_28398"},{"id":"A420","pred":"chebi_id","subj":"T420","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"}],"text":"The anti-HBV mechanism of PGS may be associated with appropriate activation of NF-κB and Raf/MEK/ERK signaling pathways to enhance the interferon system, and interfere with HBV transcription (Fig. 7 )."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T63","span":{"begin":101,"end":119},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T64","span":{"begin":101,"end":110},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T65","span":{"begin":177,"end":190},"obj":"http://purl.obolibrary.org/obo/GO_0006351"}],"text":"The anti-HBV mechanism of PGS may be associated with appropriate activation of NF-κB and Raf/MEK/ERK signaling pathways to enhance the interferon system, and interfere with HBV transcription (Fig. 7 )."}

{"project":"LitCovid-sentences","denotations":[{"id":"T173","span":{"begin":0,"end":201},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The anti-HBV mechanism of PGS may be associated with appropriate activation of NF-κB and Raf/MEK/ERK signaling pathways to enhance the interferon system, and interfere with HBV transcription (Fig. 7 )."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T805","span":{"begin":9,"end":12},"obj":"NCBITaxon:10376"},{"id":"T806","span":{"begin":79,"end":81},"obj":"GO:0005883"},{"id":"T807","span":{"begin":89,"end":92},"obj":"PR:P11345"},{"id":"T808","span":{"begin":93,"end":96},"obj":"GO:0000165"},{"id":"T809","span":{"begin":101,"end":110},"obj":"GO:0000165"},{"id":"T810","span":{"begin":173,"end":176},"obj":"NCBITaxon:10376"},{"id":"T4173","span":{"begin":47,"end":49},"obj":"GO:0005883"},{"id":"T92076","span":{"begin":57,"end":60},"obj":"PR:P11345"},{"id":"T11200","span":{"begin":136,"end":139},"obj":"NCBITaxon:10376"}],"text":"The anti-HBV mechanism of PGS may be associated with appropriate activation of NF-κB and Raf/MEK/ERK signaling pathways to enhance the interferon system, and interfere with HBV transcription (Fig. 7 )."}

{"project":"MyTest","denotations":[{"id":"980","span":{"begin":79,"end":84},"obj":"Gene"},{"id":"981","span":{"begin":89,"end":92},"obj":"Gene"},{"id":"982","span":{"begin":93,"end":96},"obj":"Gene"},{"id":"983","span":{"begin":97,"end":100},"obj":"Gene"},{"id":"984","span":{"begin":9,"end":12},"obj":"Species"},{"id":"985","span":{"begin":173,"end":176},"obj":"Species"}],"attributes":[{"id":"A980","pred":"tao:has_database_id","subj":"980","obj":"Gene:4790"},{"id":"A981","pred":"tao:has_database_id","subj":"981","obj":"Gene:22882"},{"id":"A982","pred":"tao:has_database_id","subj":"982","obj":"Gene:5609"},{"id":"A983","pred":"tao:has_database_id","subj":"983","obj":"Gene:2048"},{"id":"A984","pred":"tao:has_database_id","subj":"984","obj":"Tax:10407"},{"id":"A985","pred":"tao:has_database_id","subj":"985","obj":"Tax:10407"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"The anti-HBV mechanism of PGS may be associated with appropriate activation of NF-κB and Raf/MEK/ERK signaling pathways to enhance the interferon system, and interfere with HBV transcription (Fig. 7 )."}